Glossary
USP <800>: hazardous drug handling, and what it does not tell you
USP <800> sets standards for handling hazardous drugs so that healthcare personnel, patients and the environment are not exposed to them — it is an occupational and environmental standard, not a preparation-quality one, and a pharmacy meeting it is telling you about how its people work rather than about how a preparation was made. USP’s own page gives it an official date of 1 December 2019 and says it became compendially applicable on 1 November 2023: two different words, four years apart, and the difference is real. As with <795> and <797>, it binds a pharmacy only where a state board or an accreditor adopted it — and Illinois adopted the compounding compendium while expressly excepting <800>.
What <800> governs
USP states the scope in one sentence, and the sentence is the whole point of this page:
USP General Chapter <800> provides standards for safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients and the environment.
Exposure. Not potency, not sterility, not how a preparation was compounded. <800> is about containment: how hazardous drugs are received, stored, handled, compounded, transported and disposed of, and what protects the people doing that work. <795> and <797> protect the preparation; this one protects everyone around it.
The correction most vendor copy needs
A pharmacy meeting <800> is not telling you that its preparations are safer, purer or better made. It is telling you that it handles hazardous drugs without exposing its staff and its environment to them. Those are different questions with different answers, and conflating them is the most common error made with this chapter.
It is a fair question to ask a pharmacy, and a meaningful one — a pharmacy that is careless with occupational exposure is unlikely to be careful elsewhere. It is simply not evidence about the vial.
Two dates, two words, four years apart
USP gives <800> an official date of 1 December 2019. It then records, separately, "November 1, 2023 – USP General Chapter <800> became compendially applicable" — the same day the revised <795> and <797> that it depends on went official.
Official and compendially applicable are not the same claim, and the gap between them is four years wide. A third phrasing is also in circulation: the accreditor ACHC writes of USP General Chapter <800> that it "became enforceable" on November 1, 2023 — that is ACHC’s characterisation, and USP’s own word is "compendially applicable". Attribute the harder word to whoever used it.
What makes it binding, and where it is carved out
Same mechanism as the other chapters: USP publishes; a state board or an accreditor makes it stick.
| Adopting body | How <800> enters | Note |
|---|---|---|
| Ohio | OAC 4729:7-1-01 defines <800> as the version dated 1 December 2022, and incorporates the NIOSH list by publication number 2025-103 (December 2024) | A version-dated adoption. The rule’s date is a fact about Ohio’s rule, not about when USP revised anything |
| Illinois | 68 Ill. Adm. Code 1330.640 adopts USP-NF (USP 47-NF 42, the 2024 Compounding Compendium) expressly excepting <800> as it pertains to handling hazardous drugs in healthcare settings | The carve-out is what makes this chapter unlike the other two: a pharmacy can be working to a state-adopted compendium in which <800> is not part of the package |
| ACHC / HDPCAB | ACHC states that "HDPCAB Accreditation Standards incorporate safety requirements of USP Chapter <800>" | Contractual rather than legal, per scope, and separate from the non-sterile and sterile accreditations |
The Illinois carve-out is the practical reason to ask rather than assume. A pharmacy in a state that adopted the compendium without this chapter is not cutting a corner; it is complying with the rule its board actually wrote.
A related chapter, <825>, covers radiopharmaceuticals. It is out of scope here, but it appears in state rule text alongside the others — California and Arizona regulate it in the same breath, while Ohio’s rule does not reference it at all.
The scope hook a buyer can actually check
<800> keys off the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, which is published by a government agency and free to read. Ohio incorporates it by publication number, which means the applicable list in a given state is itself version-dated — the same staggering that affects every other part of this subject.
So the useful question is not "do you follow <800>" but "which NIOSH list edition are you working to, and did your state adopt this chapter at all".
What you can ask a pharmacy to demonstrate
- Whether their state adopted this chapter, and in which version. Illinois shows that the answer is not automatically yes.
- Which NIOSH list edition their handling programme is built on.
- Hazardous-drug accreditation, by name. HDPCAB is the ACHC programme that incorporates <800>; it is separate from PCAB non-sterile and PCAB sterile. "Accredited" with no scope named answers nothing — ask which.
- State licensure in your own state, including non-resident licensure. ACHC is explicit that a receiving state’s board may require a licence dependent on a non-resident inspection and that "This is not the same as accreditation." A prescriber checks both rather than treating one as the other.
What this chapter is not
It is not a preparation-quality standard, as above. It is not certification: USP does not certify, approve or accredit compounding pharmacies, and there is no such credential for a pharmacy to hold. And it is not FDA approval — compounded drugs are not FDA-approved, which FDA explains as meaning it does not review them for safety, effectiveness or quality before they reach patients.
Any of those three, said about a pharmacy, is a claim this page exists to head off.
Where this sits
<795> covers non-sterile preparations and <797> covers sterile ones, including beyond-use dating. The glossary index compares all three, and the pathway question behind them — who is exempt from what — is 503A vs 503B.
If you are vetting a supplier for the first time, these questions belong alongside the ones in placing an office-use order.